It is time to drop euphemisms like DNA medicines and gene-based medicines. Gene therapy, says Nuala Moran, has made it through to the commercial mainstream.
Two of Europe’s gene therapy pioneers have reported significant progress in the last week, bringing commercial gene therapy products yet closer to reality.
After the initial hype, the long haul through clinical development and the inevitable pitfalls, gene therapy is on the verge of becoming a commercial reality in Europe - ahead of the US.